Stock Report

Download full stock data and analysis for free Last Updated: 09-May-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Genenta Science SpA ADR (GNTA)

Stock Card factsheet share-fund-plan-icon

$0.63

up-down-arrow $-0.01 (-2.20%)

As on 08-May-2026 16:00EDT

Market cap

info icon

$16 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.6

Div. Yield

info icon

0 %

Genenta Science SpA ADR (GNTA) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

Price P/E Ratio P/B Ratio
NASDAQ
NASDAQ

Stock Range

Today’s Range

Low: 0.61 High: 0.66

52 Week Range

Low: 0.59 High: 10.00

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $-7 Mln

  • ROEROE information

    -0.4 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    -11.5

  • Debt to EquityDebt to Equity information

    0.3

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $--

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    23,591,020

5 Years Aggregate

CFO

€-33.89 Mln

EBITDA

€-40.46 Mln

Net Profit

€-30.81 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Genenta Science SpA ADR (GNTA)
-58.0 -9.6 -15.1 -84.6 -51.7 -- --
BSE Sensex
-8.7 3.6 -7.5 -4.2 8.2 9.5 11.9
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 08-May-2026  |  #As on 26-Oct-2023
Company
2025
2024
2023
Genenta Science SpA ADR (GNTA)
-65.7 -12.0 -10.0
S&P Small-Cap 600
4.0 7.0 13.9
BSE Sensex
9.1 8.1 18.7

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
Quarterly Annual

*All values are in (€ Mln)

Annual

*All values are in (€ Mln)

Annual

*All values are in (€ Mln)

Key Ratios

View Details

5Y Avg -- 3Y Avg -- TTM --

P/E Ratio

--

--Min --Median --Max

P/B Ratio

--

--Min --Median --Max

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

Peers

View Details
Company
 Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Genenta Science SpA ADR (GNTA)
0.6 16.3 0.0 -6.3 -- -36.5 -- 0.6
Ascendis Pharma A/S - ADR
238.7 14,573.8 691.7 -219.0 -13.7 163.2 -- 78.1

Shareholding Pattern

View Details
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Genenta Science SpA ADR (GNTA)

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical...  trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. The company is developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. In addition, it develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. The company was incorporated in 2014 and is headquartered in Milan, Italy. Address: Via Olgettina No. 58, Milan, MI, Italy, 20132  Read more

  • Vice Chairman of the Board, CEO & GM

    Mr. Pierluigi Paracchi

  • Vice Chairman of the Board, CEO & GM

    Mr. Pierluigi Paracchi

  • Headquarters

    Milan, MI

  • Website

    https://www.genenta.com

Value Research Ratings

Our rating system has guided millions of investors in the past 20 years.

Top Rated Stocks

All stocks with 5-star Value Research Ratings

Top Rated Stocks Icon

High Quality Small Caps

Small-cap stocks rated high on quality score

High Quality Small Caps Icon

High Growth Large Caps

Large-cap stocks with a high growth score

High Growth Large Caps Icon

Value Meets Momentum

Top momentum stocks with a high valuation score

Value Meets Momentum Icon

Top Rated Banks

Banks that rate high on Value Research Stock Ratings

Top Rated Banks Icon
Explore Screeners
Edit peer-selector-edit

FAQs for Genenta Science SpA ADR (GNTA)

The share price of Genenta Science SpA ADR (GNTA) is $0.63 (NASDAQ) as of 08-May-2026 16:00 EDT. Genenta Science SpA ADR (GNTA) has given a return of -51.68% in the last 3 years.

Since, TTM earnings of Genenta Science SpA ADR (GNTA) is negative, P/E ratio is not available.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
--
--
2024
--
--
2023
--
--
2022
--
--
2021
--
--

The 52-week high and low of Genenta Science SpA ADR (GNTA) are Rs 10.00 and Rs 0.59 as of 09-May-2026.

Genenta Science SpA ADR (GNTA) has a market capitalisation of $ 16 Mln as on 07-May-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Genenta Science SpA ADR (GNTA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.